Swiss National Bank
REGN icon

Swiss National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$170M Buy
323,700
+18,900
+6% +$9.92M 0.1% 169
2025
Q1
$193M Sell
304,800
-1,500
-0.5% -$951K 0.14% 126
2024
Q4
$218M Sell
306,300
-15,300
-5% -$10.9M 0.15% 113
2024
Q3
$338M Buy
321,600
+2,000
+0.6% +$2.1M 0.22% 74
2024
Q2
$336M Sell
319,600
-1,200
-0.4% -$1.26M 0.23% 72
2024
Q1
$309M Sell
320,800
-13,000
-4% -$12.5M 0.22% 82
2023
Q4
$293M Sell
333,800
-13,300
-4% -$11.7M 0.22% 85
2023
Q3
$286M Sell
347,100
-41,200
-11% -$33.9M 0.22% 80
2023
Q2
$279M Sell
388,300
-36,700
-9% -$26.4M 0.19% 97
2023
Q1
$349M Sell
425,000
-10,600
-2% -$8.71M 0.24% 79
2022
Q4
$314M Sell
435,600
-32,572
-7% -$23.5M 0.23% 88
2022
Q3
$323M Buy
468,172
+5,300
+1% +$3.65M 0.23% 76
2022
Q2
$274M Buy
462,872
+5,000
+1% +$2.96M 0.19% 102
2022
Q1
$320M Buy
457,872
+58,400
+15% +$40.8M 0.18% 98
2021
Q4
$252M Sell
399,472
-14,500
-4% -$9.16M 0.15% 116
2021
Q3
$251M Sell
413,972
-15,400
-4% -$9.32M 0.16% 112
2021
Q2
$240M Sell
429,372
-177,450
-29% -$99.1M 0.15% 124
2021
Q1
$287M Buy
606,822
+10,700
+2% +$5.06M 0.19% 103
2020
Q4
$288M Buy
596,122
+26,000
+5% +$12.6M 0.2% 101
2020
Q3
$319M Buy
570,122
+90,500
+19% +$50.7M 0.25% 76
2020
Q2
$299M Buy
479,622
+165,400
+53% +$103M 0.25% 75
2020
Q1
$153M Buy
314,222
+58,800
+23% +$28.7M 0.16% 131
2019
Q4
$95.9M Sell
255,422
-11,400
-4% -$4.28M 0.1% 210
2019
Q3
$74M Buy
266,822
+4,422
+2% +$1.23M 0.08% 262
2019
Q2
$82.1M Sell
262,400
-3,800
-1% -$1.19M 0.09% 240
2019
Q1
$109M Buy
266,200
+7,400
+3% +$3.04M 0.12% 185
2018
Q4
$96.7M Buy
258,800
+5,100
+2% +$1.9M 0.12% 178
2018
Q3
$103M Sell
253,700
-8,100
-3% -$3.27M 0.11% 190
2018
Q2
$90.3M Buy
261,800
+7,900
+3% +$2.73M 0.1% 209
2018
Q1
$87.4M Sell
253,900
-35,000
-12% -$12.1M 0.11% 207
2017
Q4
$109M Buy
288,900
+400
+0.1% +$150K 0.12% 184
2017
Q3
$129M Buy
288,500
+3,100
+1% +$1.39M 0.15% 152
2017
Q2
$140M Buy
285,400
+10,100
+4% +$4.96M 0.17% 137
2017
Q1
$107M Buy
275,300
+59,300
+27% +$23M 0.13% 174
2016
Q4
$79.3M Buy
216,000
+1,700
+0.8% +$624K 0.13% 184
2016
Q3
$86.2M Sell
214,300
-2,100
-1% -$844K 0.14% 162
2016
Q2
$75.6M Buy
216,400
+17,300
+9% +$6.04M 0.12% 187
2016
Q1
$68.8M Buy
199,100
+60,600
+44% +$20.9M 0.13% 178
2015
Q4
$75.2M Buy
138,500
+2,900
+2% +$1.57M 0.18% 123
2015
Q3
$63.1M Buy
135,600
+13,800
+11% +$6.42M 0.16% 143
2015
Q2
$62.1M Buy
121,800
+300
+0.2% +$153K 0.16% 146
2015
Q1
$54.9M Buy
121,500
+48,000
+65% +$21.7M 0.15% 161
2014
Q4
$30.2M Sell
73,500
-2,100
-3% -$862K 0.11% 197
2014
Q3
$27.3M Sell
75,600
-700
-0.9% -$252K 0.1% 212
2014
Q2
$21.6M Buy
76,300
+800
+1% +$226K 0.08% 266
2014
Q1
$22.7M Sell
75,500
-6,900
-8% -$2.07M 0.09% 240
2013
Q4
$22.7M Sell
82,400
-700
-0.8% -$193K 0.09% 245
2013
Q3
$26M Buy
83,100
+1,900
+2% +$594K 0.11% 219
2013
Q2
$18.3M Buy
+81,200
New +$18.3M 0.08% 264